Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.06
Delayed Data
As of Feb 12
 +0.03 / +1.48%
Today’s Change
1.50
Today|||52-Week Range
5.05
-32.90%
Year-to-Date

Today’s Trading

Previous close2.03
Today’s open2.05
Day’s range1.90 - 2.08
Volume599,458
Average volume (3 months)957,667
Market cap$195.2M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+13.73%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EARSAuris Medical Holdin...+0.15+3.57%
AXGNAxoGen Inc-0.18-3.60%
CUTRCutera Inc-0.06-0.55%
ENTLEntellus Medical Inc-0.44-2.75%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers